Enanta Enters $75 Million At-the-Market Stock Offering Agreement
Enanta Pharmaceuticals (ENTA) said Thursday it entered into an at-the-market offering agreement under which it may offer and sell up to $75 million of its common stock from time to time. The company said it has no obligation to sell any shares under the agreement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.